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Abstract
Background: Dystonia is characterized by sustained or intermittent muscle contractions resulting in abnormal, often repetitive, movements, postures, or both.
Neuropathologic research has been essential in understanding the etiology and disease progression of other movement disorders, including Parkinson’s disease and
cerebellar ataxias. In the field of dystonia, however, research is stymied by the paucity of post-mortem tissue available and the phenotypic heterogeneity found in
those with dystonia.
Methods: A PubMed search was conducted using the term ‘‘neuropathology of dystonia’’. The resulting list of references was limited to English-language human
neuropathology articles. A total of 20 publications were retrieved and reviewed.
Results: Historically, based on study of acquired forms of dystonia, lesions of the putamen and globus pallidus have been identified as causing dystonia. After the
identification of genetic causes of dystonia and the study of limited tissue available from those cases, as well as findings from cases of isolated focal and segmental
dystonia, there is evidence that brainstem cholinergic neurons and specific cell populations within the cerebellum also play a role in the pathophysiology of dystonia.
Discussion: Based on limited available brain tissue, there is evidence that the pathophysiology of dystonia may involve a combination of dysfunction within
neurons of the brainstem, cerebellum, putamen, and globus pallidus. In order to gain a better understanding of the pathophysiology of dystonia, a prospective,
quantitative study in well-phenotyped subjects with different types of genetic and isolated dystonia is required.
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Introduction
Dystonia is a neurologic disorder that is characterized by sustained
or intermittent muscle contractions resulting in abnormal, often
repetitive, movements, postures, or both.1 Dystonia may be classified
according to its clinical characteristics and its presumed etiology.
Clinical characteristics that are used in the current classification
scheme include age of onset, bodily distribution, temporal pattern, and
presence or absence of another movement disorder. In addition, cases
of dystonia are referred to either as isolated, meaning that dystonia is
the only motor feature with the exception of tremor, or combined,
meaning that dystonia is combined with other movement disorders,
such as Parkinsonism. Categories of presumed etiology include evi-
dence of degeneration or a structural lesion and whether the dystonia
is inherited, acquired, or idiopathic. Inherited dystonias include those
caused by autosomal dominant or recessive gene mutations, as well as
those resulting from mutations on either the X chromosome or in
mitochondrial genes. Acquired dystonias are those due to nervous
system insult, such as infection, vascular insult, or brain injury. Lastly,
many cases of adult-onset focal dystonia fall into the category of
idiopathic.
Neuropathology has been essential in understanding the etiology
and disease progression of many neurological disorders, including
Alzheimer’s disease, Parkinson’s disease, and cerebellar ataxias. In
Parkinson’s disease, in particular, degeneration of dopaminergic
neurons in the substantia nigra pars compacta leads to clinical features
of the disease. In the field of dystonia, however, neuropathologic
studies have had minimal impact on our understanding of the
underlying disease mechanisms. The majority of the published work
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has involved non-quantitative neuropathologic analysis, in which the
loss of up to 40% of a particular cell type will not be apparent.
Research is stymied by the paucity of post-mortem tissue available for
study, the lack of systematic quantitative assessment of the existing
tissue, and the phenotypic heterogeneity found in those with dystonia.
The purpose of this review is to summarize the state of knowledge
regarding neuropathologic abnormalities that may contribute to the
pathogenesis of genetic and isolated dystonias. One hypothesis of
the pathogenesis of dystonia is that multiple intracellular defects may
result in a similar abnormality at the level of brain circuitry, thus
producing a similar phenotype. This review summarizes neuropatho-
logic analyses of brains from both isolated and combined dystonias in
which the genetic mutation is known and from cases of isolated
dystonia in which no genetic etiology is suspected or known, in order
to determine the extent to which evidence exists that supports the
hypothesis of ‘‘multiple defects, similar phenotype’’.
Methods
A PubMed search was conducted on March 11, 2018, using the
term ‘‘neuropathology of dystonia’’. Because of the scarcity of neuro-
pathology reports in dystonia, no date limit was applied to the search.
A total of 127 articles were identified. The reference list was further
limited to articles written in English that analyzed human brain tissue
and focused on either isolated dystonia or combined dystonia in which
the underlying gene mutation was identified and there was no known
symptomatology outside the nervous system (thus excluding diseases
such as Wilson’s and mitochondrial disorders). Publications in which
there was limited clinical information that made it difficult to reliably
classify the type of dystonia were also excluded.2,3 In addition, move-
ment disorders in which dystonia occurs as the disease progresses,
rather than being a primary and early feature of the disease, such as
Huntington’s and Parkinson’s, were excluded, as the goal in this review
was to focus on disorders in which dystonia is part of the primary
pathology. Additional criteria to exclude reports of paroxysmal dystonia
and cases associated with developmental delay or regression were
applied. Commentary and review articles were also excluded. During
the writing of this article, an additional report of secondary dystonia
cases was included,2 in order to provide readers with a more
comprehensive background. In total, 20 neuropathology reports
were retrieved and reviewed.
Results
Acquired dystonia
Prior to the identification of dystonia-causing gene mutations,
retrospective imaging analysis of acquired forms of dystonia revealed
that lesions of the lentiform nucleus most commonly caused dystonia.4
These data pointed to the putamen and globus pallidus as playing an
essential role in motor control. However, acquired dystonias arise
because of a variety of insults, resulting in a heterogeneous sample for
study. The identification of dystonia-causing mutations allowed
neuropathologic analysis of more homogeneous samples.
Genetic dystonias
DYT1. DYT1 is an isolated dystonia, as there are no other neurologic
features with the exception of tremor. The DYT1 gene mutation
consists of a 3-bp (GAG) deletion in the coding region of the TOR1A
gene that encodes the protein torsinA.5 While the function of torsinA is
not fully understood, the totality of evidence indicates that it is
associated with the nuclear envelope and plays a role in intracellular
trafficking and secretion of proteins.6 Initial neuropathologic studies
focused on identifying the localization of wild-type torsinA in control
human brains. TorsinA mRNA was found to be enriched in the
substantia nigra pars compacta, hippocampus, and cerebellum in
control tissue.7 Subsequent analyses of TorsinA protein expression
in both control and DYT1 cases revealed varying results (summarized
in Table 1). Two independent reports focused on torsinA expression
in the substantia nigra, neostriatum, and cerebellum, and did not find
any difference in the pattern of torsinA immunoreactivity between
DYT1 and control brains.8,9 The second report also analyzed the
substantia nigra from three of the DYT1 brains and found a
semiquantitative difference in the nigral dopaminergic neurons, which
appeared to be larger and more closely spaced together in the DYT1
brains when than in the control tissue.9 A combined total of seven
unique DYT1 cases were used in these two publications. Neither
report included an analysis of brainstem tissue. Subsequent research,
which included studies of the brainstem tissue, reported intraneuronal
inclusions within cholinergic neurons in the pedunculopontine nucleus,
cuneiform nucleus, and periaqueductal gray matter.10 These inclusions
were immunoreactive for ubiquitin, the nuclear envelope marker
lamin A/C, and torsinA. A total of four DYT1 cases were analyzed.
A review of demographic data revealed that three of the cases had
most likely been utilized previously by Rostasy et al.9 and the fourth
case had most likely been utilized previously by Walker et al.8 How-
ever, the previous studies did not analyze brainstem tissue. The
presence of inclusions in brainstem nuclei that are known to play a role
in locomotor control raises the possibility that neuronal dysfunction in
this region plays a role in the pathology of DYT1 dystonia.
Two additional studies11,12 sought to reproduce the findings of
brainstem, intraneuronal inclusions by McNaught et al.10 Using a
somewhat different panel of antibodies for immunohistochemistry,
Paudel et al.11 did not find evidence of protein aggregates within
neurons of the midbrain. However, the anti-lamin A/C antibody was
not utilized, which may have identified torsinA aggregates associated
with the nuclear envelope. A more recent analysis of DYT1 brain
tissue also failed to reveal intraneuronal inclusions.12 The authors
studied brain tissue from six genetically confirmed cases of DYT1, four
of which had likely been analyzed previously by Paudel et al.11 The
authors used antibodies to torsinA, ubiquitin protein conjugate (UPC),
and choline acetyl transferase (ChAT) to analyze tissue from the
midbrain and striatum. No intraneuronal inclusions were identified
and immunoreactivity for torsinA, ChAT, and UPC was similar
between the DYT1 and control groups.
In a more recent study, a quantitative assessment was performed to
determine average cell body, nuclear, and nucleolar volume of nigral
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neurons in two DYT1 brains from subjects who manifested signs of
dystonia.13 Compared with both the two DYT1 brains from subjects
without dystonia and the two age-matched control subjects, the DYT1
manifesting subjects displayed a quantitative increase in volume of
the cell body, nuclear, and nucleolar volume of nigral pigmented
dopaminergic neurons. The authors also used antibodies to alpha-
synuclein, tau, b-amyloid, ubiquitin, phosphorylated-TAR-DNA
binding protein-43, torsinA, and lamin A/C to identify inclusions
within the substantia nigra, and none were identified.
DYT5a. DYT5a, also known as Segawa syndrome, is an isolated
dystonia caused by one of a variety of mutations in the Guanosine
triphosphate (GTP) cyclohydrolase 1 gene (GCH1).14 Limited neuro-
pathologic studies included biochemical analysis of two brains revealed
a reduction in striatal levels of both biopterin and tyrosine hydroxylase
when compared with age-matched control cases.15 Additional neuro-
anatomic studies have revealed a reduction in melanin-containing
neurons in the substania nigra pars compacta in a single brain
compared with an age-matched control subject.16
DYT6. DYT6 is also classified as an isolated dystonia. Mutations in the
transcription factor, thanatos-associated protein domain containing
apoptosis-associated protein 1 (THAP1) result in DYT6 dystonia.17
A single report on tissue from two subjects with DYT6 dystonia, each
with a different DYT6 mutation, did not reveal any evidence of signif-
icant neuronal loss.18 In addition, there was no evidence of ubiquitin
immunoreactive inclusions in the midbrain.
DYT3. DYT3 is a combined dystonia, with affected individuals
displaying features of Parkinsonism as well. The most frequently
documented clinical phenotype consists of an initial focal dystonia that
spreads to multiple body regions over time and combines with, or is
replaced by, Parkinsonism.19–23 Recently, the causal locus was iden-
tified as a hexameric repeat expansion within the Short Interspersed
Nuclear Elements-Variable Number of Tandem Repeats-Alu (SINE-
VNTR-Alu) intronic region of the TAF-1 gene on the X chromo-
some.24 Like other repeat expansion disorders, a larger repeat length
correlated with an earlier age at onset of symptoms. Neuropathologic
data from a limited number of DYT3 cases, consisting of elemental
immunohistochemical staining, revealed preferential loss of medium
spiny neurons in the striosomal component during the dystonic phase of
the disease, with more widespread loss of striosomal and matrix
component neurons, with evidence of astrocytosis, as the disease
progresses and subjects display more parkinsonian signs.25,26
Immunohistochemical analysis of striatal tissue from four X-linked
Dystonia Parkinsonism (XDP) subjects revealed a decrease in
neuropeptide Y-positive cells in the caudate and putamen compared
with control tissue.27
DYT12. DYT12 is also a combined dystonia, as subjects display
features of Parkinsonism and dystonia. The disorder is associated
with mutations in the ATP1A3 gene, which encodes the alpha subunit
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sodium and potassium gradients across cell membranes.28 A report
of four family members who carried a DYT12 mutation, with three
of them affected, revealed neuronal loss and gliosis in the globus
pallidus and subthalamic nucleus in all the affected siblings when
compared with 16 control cases.29 The cerebellum and midbrain
were available from two of the three affected siblings, and revealed
mild to moderate neuronal loss and gliosis in the Purkinje and granule
cell layers of the cerebellum, as well as the dentate nucleus. Neuronal cell
loss was also found in the periaqueductal gray matter, red nucleus, and
inferior olivary nucleus. Tissue from the asymptomatic sibling did not
reveal significant degeneration in those regions.
Isolated focal/segmental dystonia
In 1988, a single case report of neuropathologic findings in Meige
syndrome, a combination of blepharospasm and lower facial dystonia,
revealed mild abnormalities that may be consistent with normal
aging.30 No immunohistochemical staining or quantitative analysis was
performed. Another report, of four patients with isolated focal or
segmental dystonia of the face and jaw, also did not reveal any
abnormalities.31 However, as with the case report, no immunohis-
tochemistry or quantitative analysis was performed. A more recent
study, of six cases of adult onset, isolated focal, and segmental dystonia,
did include immunohistochemical analysis.32 There was no evidence of
pathology similar to that seen in DYT1 dystonia, namely neuronal
inclusions immunoreactive for torsinA or ubiquitin.8 In addition, there
was no evidence of neuronal loss in the striosome compartment of the
striatum, as has been demonstrated in DYT3 dystonia.26 Thus, the
limited number of adult-onset isolated focal/segmental dystonias do
not appear to demonstrate pathology similar to that seen in genetic
forms of dystonia (summarized in Table 2).
Cervical dystonia
Additional neuropathologic analysis has been done on cases that
share a single phenotype, namely focal cervical dystonia.33 Prudente
et al.33 analyzed post-mortem brain tissue from six subjects with
cervical dystonia and compared them with 16 control subjects. Using a
two-stage approach, an experienced neuropathologist examined tissue
from four of the cervical dystonia subjects for overt changes. This
subjective assessment revealed ubiquitin-positive inclusions in nigral
neurons and patchy loss of cerebellar Purkinje cells. In the second
stage of the analysis, quantitative assessment for nigral inclusions and
Purkinje cell number was performed. While there was no significant
difference in the number of ubiquitin-positive inclusions in the nigra,
there was a significantly lower density of Purkinje cells in the cere-
bellum from those with cervical dystonia.
Recently another case series, focusing on the cholinergic system,
was conducted on eight cervical dystonia subjects and seven control
subjects.34 In the pedunculopontine nucleus (PPN), but not the putamen,
of the cervical dystonia patients, there was markedly decreased or absent
choline acetyltransferase staining, indicating the presence of a functional
cholinergic deficit in cervical dystonia. However, stereologic quantifi-
cation of the difference in staining in the PPN was not reported.
In addition, there was no evidence of an underlying neurodegenerative
process, as assessed by lack of gliosis and lack of beta-amyloid, tau, and
alpha-synuclein pathologies.
Conclusion
Traditionally, dystonia has been regarded as a disorder arising
within the basal ganglia.4 The availability of post-mortem tissue from a
limited number of genetic and focal dystonia cases has allowed the
existence of neuropathologic lesions throughout the brain to be
explored. While the number of unique cases is limited, the largest body
of evidence is from analysis of DYT1 and cervical dystonia cases.
The DYT1 cases were not all analyzed in the same manner, because
different groups analyzed varying brain regions and antibody com-
binations. In the few cases in which intraneuronal aggregates were
found, they were located in the brainstem.10 Similarly, brainstem
abnormalities were identified in cases of isolated cervical dystonia, in
the form of reduced cholinergic immunostaining.34 Taken together,
these data indicate that brainstem nuclei, and basal ganglia nuclei,
may play a role in the pathophysiology of dystonia.
While the primary dystonias have not revealed consistent evidence
of cell loss or neuronal pathology, the combined dystonias have shown
evidence of degeneration. Cases of DYT12 dystonia displayed neuro-
nal loss in multiple layers of the cerebellum.28 Cases of DYT3 dystonia
have shown selective loss of neurons within specific populations of
the basal ganglia.26 Subsequent analysis of four XDP brains indicates
that neuropeptide Y may play a role in the preferential vulnerability
of striatal neurons in DYT3.27 However, the tissue was not subjected
to rigorous, quantitative analysis.
Taken together, the available data from neuropathologic studies do
not reveal solid evidence of marked neuronal loss within the striatum,
cerebellum, and brainstem nuclei in different forms of dystonia. How-
ever, the number of cases examined is limited, and rigorous quan-
tification of different cell types in each region has not been performed.
A large, prospective and quantitative neuropathologic study in clinically
well-characterized patients with genetic and focal dystonias is required to
better understand the pathology of dystonia.
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